An e-liquid for forming an aerosol in a vaping define, the e-liquid comprising an inhibitor for inhibiting the formation of reactive carbonyl species (RCS) (i.e. a dicarbonyl compound, formaldehyde, acetaldehyde, glyoxal, methylglyoxal) within the e-liquid and/or the aerosol formed therefrom, wherein the inhibitor comprises at least one polyphenol compound (i.e. gallic acid, pyrogallol, homovanillic acid, hydroxytyrosol, epigallocatechin gallate, flavonoids, isoflavinoids, neoflavinoids, flavonols, flavanols, flavones, flavanones, isoflavones, anthocyanidins, anthoxanthins, catechin). The inhibitor may be present in the e-liquid in a concentration from 0.01mM - 1.0mM, preferably 0.05mM - 0.5mM. The e-liquid may further comprise glycerol and a glycol which make up at least 90% by weight of the composition. The e-liquid may be for use in e-cigarettes, electronic cigars, pipers, and/or shisha sticks, and also claimed is a vaping device comprising such an e-liquid. The e-liquid may reduce the risk of cancer, cardiovascular disease and/or respiratory disease caused by the inhalation of an aerosol produced from the e-liquid in a vaping device.

E-Liquid / EDRYD STEPHENS, William; Fiore, Alberto; DE FALCO, Bruna. - (2019).

E-Liquid

ALBERTO FIORE;BRUNA DE FALCO
2019

Abstract

An e-liquid for forming an aerosol in a vaping define, the e-liquid comprising an inhibitor for inhibiting the formation of reactive carbonyl species (RCS) (i.e. a dicarbonyl compound, formaldehyde, acetaldehyde, glyoxal, methylglyoxal) within the e-liquid and/or the aerosol formed therefrom, wherein the inhibitor comprises at least one polyphenol compound (i.e. gallic acid, pyrogallol, homovanillic acid, hydroxytyrosol, epigallocatechin gallate, flavonoids, isoflavinoids, neoflavinoids, flavonols, flavanols, flavones, flavanones, isoflavones, anthocyanidins, anthoxanthins, catechin). The inhibitor may be present in the e-liquid in a concentration from 0.01mM - 1.0mM, preferably 0.05mM - 0.5mM. The e-liquid may further comprise glycerol and a glycol which make up at least 90% by weight of the composition. The e-liquid may be for use in e-cigarettes, electronic cigars, pipers, and/or shisha sticks, and also claimed is a vaping device comprising such an e-liquid. The e-liquid may reduce the risk of cancer, cardiovascular disease and/or respiratory disease caused by the inhalation of an aerosol produced from the e-liquid in a vaping device.
2019
E-Liquid / EDRYD STEPHENS, William; Fiore, Alberto; DE FALCO, Bruna. - (2019).
File in questo prodotto:
File Dimensione Formato  
GB2589153B_Patent.pdf

accesso aperto

Descrizione: Documento brevetto
Tipologia: Altro materiale allegato
Licenza: Accesso privato/ristretto
Dimensione 1.81 MB
Formato Adobe PDF
1.81 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/957508
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact